Selective β 2 -Adrenoreceptor Stimulation Attenuates Myocardial Cell Death and Preserves Cardiac Function After Ischemia–Reperfusion Injury
Author(s) -
Shashi Bhushan,
Kazuhisa Kondo,
Benjamin L. Predmore,
Maxim Zlatopolsky,
Adrienne L. King,
Claire Pearce,
Hui Huang,
YaXiong Tao,
Marah E. Condit,
David J. Lefer
Publication year - 2012
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.112.251769
Subject(s) - medicine , enos , protein kinase b , cardioprotection , reperfusion injury , myocardial infarction , stimulation , endocrinology , ischemia , troponin i , troponin t , ejection fraction , cardiology , phosphorylation , heart failure , nitric oxide synthase , chemistry , nitric oxide , biochemistry
β(2)-adrenoreceptor activation has been shown to protect cardiac myocytes from cell death. We hypothesized that acute β(2)-adrenoreceptor stimulation, using arformoterol (ARF), would attenuate myocardial ischemia/reperfusion (R) injury via NO synthase activation and cause a subsequent increase in NO bioavailability.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom